Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.
about
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@en
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@nl
type
label
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@en
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@nl
prefLabel
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@en
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@nl
P2093
P2860
P1433
P1476
Disruption of ETV6 leads to TW ...... inhibitors in prostate cancer.
@en
P2093
Hsiu-Lien Yeh
Juan Juan Yin
Wassim Abou-Kheir
Wei-Yu Chen
Yen-Nien Liu
Yi-Chao Lee
Yuan-Chin Tsai
P2860
P2888
P356
10.1186/S12943-018-0785-1
P577
2018-02-19T00:00:00Z
P6179
1101066786